Can Tolvaptan (OTSUKA) be a useful drug for patients with ADPKD? How could future treatment of patients change with Adpkd?

Authors

  • F. Scolari Direttore II U.O. di Nefrologia e Dialisi, P.O. Montichiari A.O. Spedali Civili Brescia, Cattedra di Nefrologia Università di Brescia Presidente Comitato Scientifico AIRP onlus

DOI:

https://doi.org/10.33393/gcnd.2012.1181

Abstract

No abstract

Downloads

Download data is not yet available.

Published

2018-01-26

How to Cite

Scolari, F. (2018). Can Tolvaptan (OTSUKA) be a useful drug for patients with ADPKD? How could future treatment of patients change with Adpkd?. Giornale Di Clinica Nefrologica E Dialisi, 24(4), 89–91. https://doi.org/10.33393/gcnd.2012.1181

Issue

Section

Polycystic kidney disease - In collaboration with AIRP

Metrics